Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

Innovative payer approaches and holistic support could help expand GLP-1 use and improve obesity care outcomes, experts claimed.

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

Emma Guttman-Yassky, MD, PhD | Image Credit: © Icahn School of Medicine at Mount Sinai

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

October 14th 2025

Optimizing ALL Treatment Through Guideline Adherence and Highly-Effective Therapies

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Group of young adults sitting down | Image credit: Drobot Dean - adobe.stock.com

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes

Guideline adherence in treating acute lymphoblastic leukemia (ALL) enhances health care resource utilization, especially for adolescent and young adult patients.

CAR T-cell therapy | Image Credit: Funny -stock.adobe.com

October 29th 2025

Innovative Payment Models, Holistic Medicaid Approaches Could Improve GLP-1 Access, Outcomes

Experts at AMCP Nexus 2025 highlighted how real-world data can improve CAR T-cell therapy access and outcomes.

Related Content

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

Innovative payer approaches and holistic support could help expand GLP-1 use and improve obesity care outcomes, experts claimed.

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

October 14th 2025

Optimizing ALL Treatment Through Guideline Adherence and Highly-Effective Therapies

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes

Guideline adherence in treating acute lymphoblastic leukemia (ALL) enhances health care resource utilization, especially for adolescent and young adult patients.

October 29th 2025